Sign in

CIK 0000715446 · Non-accelerated filer<br>Smaller reporting company

Anixa Biosciences Inc

Sign in to watch
Ticker
ANIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Oct 31
Incorporated
DE
Entity type
operating
EIN
112622630
Phone
408-708-9808
Business address
3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
Former names
ITUS Corp, COPYTELE INC
  1. 4 Open-market buy Chief Executive Officer bought 10,000 shares at $3.73 ($37,300)
  2. 8-K Event Material agreement
  3. S-8 Other Securities Offered to Employees in Benefit Plans
  4. 10-K Report Annual Report
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 8-K Event Material agreement
  8. 4 Other acquisition COO & CFO acquired 1,918 shares (other)
  9. 8-K Event Regulation FD disclosure
  10. 4 Open-market buy Director bought 40,000 shares at $2.08 ($83,200)
  11. 4 Open-market buy Chief Executive Officer bought 28,000 shares at $2.11 ($59,080)
  12. 10-Q Report Quarterly Report
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 8-K Event Bylaws or fiscal year change · Shareholder vote results
  19. DEFA14A Proxy Proxy Materials
  20. DEF 14A Proxy Proxy Statement

Page 11 of 50 · 983 filings